• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Priceline - 2014 Q2: Excellent results; but overvalued

  • ID: 2977464
  • February 2014
  • 51 Pages
  • Indigo Equity Research

This report provides a detailed financial analysis and review of the company. The report includes: SWOT analysis, investment thesis, fundamental & DCF Valuation; as well as a review of significant recent events, operations analysis, ten year financial analysis, business model, strategy, major M&A activity, industry overview and latest Q results.

Independent, buy-side, fundamental, financial analysis.

Note: Product cover images may vary from those shown

Investment Thesis & SWOT Analysis

News Flow - Significant Recent Events

Company Analysis
Company Overview
Management, Executive Compensation & Board
Description of Revenues (Gross Profits)
Business Model - Snapshot of the last 12 Months
SWOT Analysis
Current Key Investment Issues

Key Fundamental Drivers

Historical Financial Results - Quarterly Analysis since 2004
Profit & Loss Summary
Revenue, Gross Profit & Bookings
Bookings & Gross Profit by Region
Operational Analysis
Productivity Analysis
Cash Flow Analysis
Balance Sheet Analysis
Return Analysis
Unusual Items

Fundamental Valuation of Priceline
DCF Valuation & Reality Check
Historical Valuation Multiples
Consensus Forecasts & Valuation Multiples
Industry Analysis
Overview of the Online Travel Industry
Mobile is taking-off
Tables of Historical Financial Results
Quarterly & Annual Financial Accounts
Revenue Data
Operational Data

Explanations, Legal and Important Information

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.